W. Lergier
Hoffmann-La Roche
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by W. Lergier.
Helvetica Chimica Acta | 1960
K. Vogler; R. O. Studer; W. Lergier; P. Lanz
In order to elucidate the structure of natural polymyxin B1 the cyclic decapeptide 8 γ(V, Fig. 3, with 8 amino acids in the ring and the side chain attached in γ-position) has been synthesized. This is one of the four possible structures deduced for the natural product by the usual degradation methods. The cyclic decapeptide 8 γ appears not to be identical with polymyxin B1 in view of its reduced antibacterial activity and different optical rotatory power.
Biochimica et Biophysica Acta | 1980
I. Bernier; A. Dautigny; B.E. Glatthaar; W. Lergier; Jacqueline Jollès; Dieter Gillessen; Pierre Jollès
Summary α 1 -Microglobulin was purified from normal and pathological urines. Significant differences were found in the amino acid compositions of the α 1 -microglobulin isolated from these two sources. In addition electrofocusing of α 1 -microglobulin from normal urine gave rise to two peaks of equal intensity with rather acidic isoelectric points (3.8 and 4.2), whilst α 1 -microglobulin from pathological urine showed two peaks in a 1:5 ratio with less acidic isoelectric points (4.2 and 4.7). Further charge heterogeneity was also observed in the second peaks from both sources. The sugar compositions were also established, as well as the N-terminal sequences of the α 1 -microglobulin of both peaks isolated from normal and pathological urines.
Biochimica et Biophysica Acta | 1976
Egon E. Rickli; W. Lergier; Dieter Gillessen
NH2-Terminal sequences were determined by the automated Edman method in four fragments which were isolated from a mixture of fragments obtained by CNBr cleavage of human plasminogen. One of the fragments whose sequence was determined over the first 31 residues shows sequence homologies with the fragment that forms the linkage between the plasmin chains and also with the non-thrombin part of prothrombin.
Regulatory Peptides | 1980
Guido A. Schoenenberger; Susanne Buser; L. B. Cueni; Heinz Döbeli; Dieter Gillesen; W. Lergier; Gertrude Schöttli; Hans J. Tobler; Kenneth J. Wilson
Two different peptides have been purified from human liver, similar to those previously reported (Schoenenberger, G.A., and Wacker, W.E.C. (1966) Biochemistry 5, 1375--1379) to be present in human urine, which may serve as metabolic regulators of lactate dehydrogenase (EC 1.1.1.27) isoenzymes (LDH-M4 = muscle type; LDH-H4 = heart type). By trichloroacetic acid precipitation, ultrafiltration, Sephadex G-25 and Bio-Gel P-2 columns, affinity chromatography on immobilized LDH-isozymes and HPLC two peptides which differed with respect to molecular weight, retention on the affinity columns and amino acid composition were isolated. No effect was observed when native, tetrameric lactate dehydrogenase was incubated with these peptides. However, when lactate dehydrogenase was dissociated to monomers at low pH and allowed to reassociate by adjusting the pH to 7.5 complete inhibition of the reactivation occurred when the inhibitors were incubated together with respective reassociating monomeric isozymes. The two peptides showed no cross-specificity, i.e. each peptide exhibited inhibitory activity only on one of the two isozymes LDH-M4 or LDH-H4. From the amino acid analyses, gel filtrations and PAGE + SDS, molecular weights of 1800 for the M4 and approximately 2700 for the H4 inhibitor were calculated. An apparent Ki of approximately 3 X 10(-5) mM for the H4 and approximately 7 X 10(-5) mM for the H4 inhibitor was estimated. The interaction of the inhibitors with the enzyme system showed strong cooperativity with Hill coefficients of 2.9 (LDH-M4-specific) and 2.4 (LDH-H4-specific). Mathematical modelling of the reassociation and reactivation of lactate dehydrogenase and its specific inhibition by the peptides led to the conclusion that the peptides react with monomers, dimers or a transition state during the tetramerisation process. kappa 1 for the dimerisation step of M4 = 2.0 X 10(5) M-1 . S-1 and of H4 = 8.2 X 10(4) M-1 . S-1; kappa 2 for the tetramerisation step of M4 = 2.8 X 10(5) M-1 . S-1 and of H4 = 1.2 X 10(5) . M-1 S-1, were calculated, the second step still being the faster one (Rudolf, R. and Jaenicke, R. (1976) Eur. J Biochem. 63, 409--417).
Peptides | 1987
Heinz Döbeli; Dieter Gillessen; W. Lergier; André Van Dijk; Guido A. Schoenenberger
The catalytic activity of lactate dehydrogenase isoenzymes (LDH) depends on their tetrameric structure. Stabilization of this quaternary structure is achieved by interaction of the N-terminal part of one subunit with the C-terminal region of the other subunit. The N-terminal peptides from pig M-LDH and H-LDH which are responsible for this stabilization were obtained by CNBr-fragmentation and purification on reversed-phase HPLC. The effect of these peptides on the formation of the quaternary structure of LDH-isoenzymes was investigated by monitoring the reconstitution of the catalytic activity after acid-dissociation. Low concentrations of the N-terminal peptides led to an increased, and high concentrations to a decreased yield of reconstituted LDH activity. The effects of these two peptides were isoenzyme specific. The 32 residue peptide derived from M-LDH showed the highest effect when tested with M-LDH as target enzyme but only a poor effect with H-LDH. On the other side the 33 residue peptide generated from H-LDH showed a moderate effect with both isoenzymes. The effects of the N-terminal LDH peptides are antagonized by the coenzymes NAD+ and NADH. The most significant influence was observed with NAD+ in the M-LDH peptide-M-LDH enzyme system. Comparison of the properties of the reactivation antagonists isolated from human origin with the N-terminal CNBr-peptides of LDH revealed identity in all essential properties, suggesting that the former peptides are generated by degradation of LDH.
Helvetica Chimica Acta | 1973
R. O. Studer; Arnold Trzeciak; W. Lergier
Annals of the New York Academy of Sciences | 2006
K. Vogler; W. Haefely; A. Hürlimann; R. O. Studer; W. Lergier; R. Strässle; K. H. Berneis
Helvetica Chimica Acta | 1970
Dieter Gillessen; W. Lergier; R. O. Studer; Arthur M. Felix
Helvetica Chimica Acta | 1965
K. Vogler; R. O. Studer; P. Lanz; W. Lergier; E. Böhni
Helvetica Chimica Acta | 1965
K. Vogler; R. O. Studer; W. Lergier; P. Lanz